The UK Medicines and Healthcare products Regulatory Agency (MHRA) has received 216 reports of suspected deaths involving GLP-1 drugs, according to data from its Yellow Card scheme. The reports include 120 deaths…
A patient with Duchenne muscular dystrophy died after receiving a gene editing therapy from Shanghai-based HuidaGene Therapeutics, the company said on Wednesday. The death occurred in August 2025 and was attributed to…
The Union Health Ministry has amended the Drugs Rules, 1945, to let licensing authorities bar applicants who submit fake or fabricated data. The action requires a show-cause notice and allows an appeal.…
UK medicines regulator data record 59 reported deaths involving semaglutide, sold as Ozempic and Wegovy, and 120 involving tirzepatide, sold as Mounjaro. Liraglutide, marketed as Saxenda, has 37 reported deaths. The figures…
Dabur India said its Silvassa pharmaceutical plant remains operational after the US Food and Drug Administration issued a warning over manufacturing deficiencies. The company said the action affects a small private-label operation…
The Union Health Ministry has amended the Drugs Rules, 1945, allowing licensing authorities to bar pharmaceutical entities from filing applications for a specified period if they submit fake or fabricated data. The…
Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.